Immorta Bio’s president discusses the company’s work with age-related diseases.
Diseases of Aging: Q&A with Dr. Thomas Ichim
Immorta Bio’s president discusses the company’s work with age-related diseases.
You may also like
FDA Grants Breakthrough Therapy Designation to...
Pharma Pulse 10/10/24: Empowering Patients in a...
New Analysis Compares Sustainable Diet Habit Results...
Leverage AI to Lower Cost, Barriers to Cell Therapies
FDA Grants Marketing Authorization for Healgen...
Study: Over 40% of Irritable Bowel Disease Patients...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.